CONSIDERATIONS TO KNOW ABOUT CML EARLY DETECTION

Select other agents are recommended as alternative brokers based on administration troubles and/or adverse outcome profile.  Zidovudine coupled with lamivudine is the choice NRTI backbone but is associated with a lot more hematologic toxicity. Lopinavir/ritonavir is an alternate PI agent with established basic safety but exhibits increased gastroi